Henry Schein Completes Acquisition of a Majority Interest in Shield Healthcare, Inc.

Henry Schein, Inc., the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, announced that it has completed the acquisition of Shield Healthcare, Inc., Leading provider of home care medical products delivered directly to patients in their homes. Henry Schein announced an agreement to acquire Shield Healthcare on August 3, 2023.Headquartered in Valencia, California, Shield Healthcare had 2022 net revenues of approximately $180 million. Henry Schein expects trading to be neutral to non-GAAP earnings per share in 2023 and incremental thereafter. Financial terms were not disclosed.
“As the health care landscape continues to shift towards home-based care, we have expanded our business delivering medical products directly to patients through our partnership with Shield Healthcare,”
“Through our strategic homecare products investments, our Henry Schein Medical business is increasingly well positioned to compete in the homecare medical supplies market. By combining our strong physician relationships, product distribution expertise, and corporate brand assortment, we are well positioned for growth in this market segment. We welcome our new Shield Healthcare colleagues to Team Schein, and we look forward to continued success together.”
Stanley M. Bergman, Chairman of the Board and Chief Executive Officer.
Building on Henry Schein’s acquisition of Prism Medical Products LLC in 2021, Shield Healthcare will expand Henry Schein’s existing medical business by offering a broad range of products, including categories such as urinary incontinence , urology, tracheostomies, enteral nutrition, advanced wound care and diabetes supplies. Additionally, it will provide continuous glucose monitoring devices directly to patients in their homes.Current owners of Shield Healthcare, including members of the company’s management board, will retain a minority stake in the company.
Next Post

Oxford Nanopore Technologies and Saphetor Announce a New Partnership to Deliver Tertiary Analysis for Comprehensive Interpretation of Nanopore Sequencing

Oxford Nanopore Technologies plc, a company providing next-generation nanopore-based molecular sensing technology, and Saphetor, a next-generation sequencing data analysis company, today announce a new partnership to support supports comprehensive analysis of nanopore sequencing data and enables comprehensive analysis of nanopore sequencing data. -end of workflow. The collaboration with Saphetor will […]